Challenges of sarcoidosis and its management

M Drent, ED Crouser, J Grunewald - New England Journal of …, 2021 - Mass Medical Soc
Sarcoidosis Sarcoidosis is a lung disease of unknown cause characterized by noncaseating
granulomas; the heart and nervous system may also be involved. It is often misdiagnosed; …

Sarcoidosis: a clinical overview from symptoms to diagnosis

P Sève, Y Pacheco, F Durupt, Y Jamilloux… - Cells, 2021 - mdpi.com
Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …

ERS clinical practice guidelines on treatment of sarcoidosis

RP Baughman, D Valeyre, P Korsten… - European …, 2021 - Eur Respiratory Soc
Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline

ED Crouser, LA Maier, KC Wilson… - American journal of …, 2020 - atsjournals.org
Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous …

Neurosarcoidosis: pathophysiology, diagnosis, and treatment

MJ Bradshaw, S Pawate, LL Koth, TA Cho… - Neurology …, 2021 - AAN Enterprises
Although often regarded as a protean illness with myriad clinical and imaging
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …

Consensus definition of misophonia: a delphi study

SE Swedo, DM Baguley, D Denys, LJ Dixon… - Frontiers in …, 2022 - frontiersin.org
Misophonia is a disorder of decreased tolerance to specific sounds or their associated
stimuli that has been characterized using different language and methodologies. The …

[HTML][HTML] Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

AC Guidon, LB Burton, BK Chwalisz… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Expanding the US Food and Drug Administration–approved indications for immune
checkpoint inhibitors in patients with cancer has resulted in therapeutic success and …

Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study

P Maggi, P Sati, G Nair, ICM Cortese… - Annals of …, 2020 - Wiley Online Library
In multiple sclerosis (MS), a subset of chronic active white matter lesions are identifiable on
magnetic resonance imaging by their paramagnetic rims, and increasing evidence supports …

Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis

AK Pröbstel, X Zhou, R Baumann, S Wischnewski… - Science …, 2020 - science.org
Changes in gut microbiota composition and a diverse role of B cells have recently been
implicated in multiple sclerosis (MS), a central nervous system (CNS) autoimmune disease …

Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm

MA Garcia, PV Barreras, A Lewis, G Pinilla… - Journal of the …, 2021 - Elsevier
Objective To study in cerebrospinal fluid (CSF) of COVID-19 subjects if a “cytokine storm” or
neuroinflammation are implicated in pathogenesis of neurological complications. Methods …